ConforMIS, Inc. (NASDAQ:CFMS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02.
|
Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
ConforMIS, Inc. (the Company), upon the recommendation of the
nominating and corporate governance committee of the Board,
elected Philip W. Johnston to the Board as a class II director,
effective as of the Companys upcoming Annual Meeting of
Stockholders, currently scheduled for May 8, 2017 (the Annual
Meeting). The Board also nominated Mr. Johnston to stand for
election at the Annual Meeting. If elected, Mr. Johnston will
serve as a class II director for a term of three years until the
Companys 2020 Annual Meeting of Stockholders, and until his
successor is elected and qualified or until his earlier death,
resignation or removal. Effective as of the Annual Meeting, the
Board has set the number of directors constituting the board at
seven.
be awarded a restricted stock grant under the Companys 2015 Stock
Incentive Plan having a fair market value of $220,000, measured
using the sixty-day average stock price on the date of grant, in
accordance with the Companys director compensation practices.
There are no understandings or arrangements between Mr. Johnston
and any other person to which Mr. Johnston was elected as a
director.
|
Item 7.01.
|
Regulation FD Disclosure.
|
the election of Mr. Johnston to the Board as a class II director
and his nomination for election at the Annual Meeting, which is
attached hereto as Exhibit 99.1.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
Exhibit
Number
|
Description
|
|
|
99.1
|
Press release dated March 31, 2017
|
About ConforMIS, Inc. (NASDAQ:CFMS)
ConforMIS, Inc. is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee. Its iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. The Company markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore and Hong Kong. ConforMIS, Inc. (NASDAQ:CFMS) Recent Trading Information
ConforMIS, Inc. (NASDAQ:CFMS) closed its last trading session 00.00 at 5.17 with 149,225 shares trading hands.
